These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 28972416)

  • 1. New insights in the treatment of nontuberculous mycobacterial pulmonary disease.
    Ruth MM; van Ingen J
    Future Microbiol; 2017 Oct; 12():1109-1112. PubMed ID: 28972416
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection.
    Martiniano SL; Wagner BD; Levin A; Nick JA; Sagel SD; Daley CL
    Chest; 2017 Oct; 152(4):800-809. PubMed ID: 28483608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First pulmonary case reported in Argentina of infection with mycobacterium szulgai, a rare pathogen.
    Gutierrez M; Feola M; Lenge L; Rey R; Hoffman M
    J Clin Microbiol; 2007 Sep; 45(9):3121-4. PubMed ID: 17596359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
    Kwon YS; Daley CL; Koh WJ
    Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
    [No Abstract]   [Full Text] [Related]  

  • 5. Medications and monitoring in nontuberculous mycobacteria infections.
    Egelund EF; Fennelly KP; Peloquin CA
    Clin Chest Med; 2015 Mar; 36(1):55-66. PubMed ID: 25676519
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of nontuberculous mycobacterial (NTM) lung disease.
    Philley JV; Griffith DE
    Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin disease and nontuberculous atypical mycobacteria.
    Palenque E
    Int J Dermatol; 2000 Sep; 39(9):659-66. PubMed ID: 11044189
    [No Abstract]   [Full Text] [Related]  

  • 9. Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
    Haworth CS; Floto RA
    Thorax; 2017 Nov; 72(11):969-970. PubMed ID: 29054887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic treatment for nontuberculous mycobacterial lung disease.
    Kang YA; Koh WJ
    Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
    Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifabutin-associated uveitis in an immunocompetent individual with Mycobacterium simiae.
    Jetton J; Gaviria JG; Patterson TF; Johnson DA
    Can J Ophthalmol; 2009 Aug; 44(4):468-9. PubMed ID: 19606179
    [No Abstract]   [Full Text] [Related]  

  • 13. Nontuberculous Mycobacteria-Overview.
    Koh WJ
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28128073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nontuberculous Mycobacterial Infections in Children.
    Bhattacharya J; Mohandas S; Goldman DL
    Pediatr Rev; 2019 Apr; 40(4):179-190. PubMed ID: 30936399
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence.
    van Ingen J; Ferro BE; Hoefsloot W; Boeree MJ; van Soolingen D
    Expert Rev Anti Infect Ther; 2013 Oct; 11(10):1065-77. PubMed ID: 24124798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal Inhibitory Concentration of Clofazimine Among Clinical Isolates of Nontuberculous Mycobacteria and Its Impact on Treatment Outcome.
    Kwak N; Whang J; Yang JS; Kim TS; Kim SA; Yim JJ
    Chest; 2021 Feb; 159(2):517-523. PubMed ID: 32712225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections.
    Banaschewski B; Verma D; Pennings LJ; Zimmerman M; Ye Q; Gadawa J; Dartois V; Ordway D; van Ingen J; Ufer S; Stapleton K; Hofmann T
    J Cyst Fibros; 2019 Sep; 18(5):714-720. PubMed ID: 31138497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Unusual Rectal Mass.
    Wang WL; Chang IW; Lee CT
    Gastroenterology; 2018 Mar; 154(4):e10-e11. PubMed ID: 28712754
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of slowly growing mycobacteria.
    Philley JV; Griffith DE
    Clin Chest Med; 2015 Mar; 36(1):79-90. PubMed ID: 25676521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged use of tedizolid in a pulmonary non-tuberculous mycobacterial infection after linezolid-induced toxicity.
    Yuste JR; Bertó J; Del Pozo JL; Leiva J
    J Antimicrob Chemother; 2017 Feb; 72(2):625-628. PubMed ID: 27999019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.